Name: heart failure: bench to bedside (en Inglés)
Price: 340690.00 CLP
Availability: InStock
Author: Marín-García, José
ISBN: 9781617796937

portada heart failure: bench to bedside (en Inglés)

Formato

Libro Físico

Autor

José Marín-García

Editorial

Humana

Año

2012

Idioma

Inglés

N° páginas

470

Encuadernación

Tapa Blanda

Dimensiones

27.4 x 21.1 x 3.0 cm

Peso

1.04 kg.

ISBN

161779693x

ISBN13

9781617796937

Categorías

Enfermedades cardiovasculares

heart failure: bench to bedside (en Inglés)

José Marín-García (Autor) · Humana · Tapa Blanda

Libro Nuevo

$ 340.690

$ 567.820

Ahorras: $ 227.130

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 30 de Mayo y el Martes 11 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "heart failure: bench to bedside (en Inglés)"

Heart Failure (HF) is the final and common pathway of all cardiovascular diseases. Heart Failure: Bench to Bedside helps address a significant need to develop new paradigms and to identify novel therapeutic targets for this pervasive disease. An authoritative contribution to the field, this book provides a detailed description of new findings and emerging methodologies, as well as a critical clinical evaluation of the complex HF syndrome and future therapies. Heart Failure: Bench to Bedside includes a primer on gene profiling and bioenergetics of the normal heart and a discussion of the molecular, genetic, biochemical and cellular techniques critical to understanding HF. Further chapters discuss cardiac remodeling, oxidative stress, and alterations in other organs and systems that are often associated with HF. This book thoughtfully evaluates current and forthcoming diagnostic techniques and therapies, pharmaceutical and pharmacogenomic-based individualized medicine, gene and cell-based therapies, and the search for new frontiers. Heart Failure: Bench to Bedside presents a clear view of up-to-date approaches to clinical diagnosis and treatment, as well as offering insightful critiques of original and creative scientific thoughts on post-genomic HF research.